top of page

Imprivata Acquires Verosint to Fuse AI Risk Detection With Passwordless Access in Healthcare and Beyond

In a move that signals the next evolution of healthcare identity security, Imprivata has acquired Verosint, a fast-growing player in Identity Threat Detection and Response (ITDR). The acquisition underscores a growing industry shift toward continuous, adaptive identity assurance—where authentication is not a one-time checkpoint, but an intelligent, risk-driven process that protects every user, from clinicians on shared workstations to third-party contractors accessing critical data.


A New Layer of Intelligence for Access Security


The deal positions Imprivata to extend its reach beyond traditional access management into active identity defense. By integrating Verosint’s AI-powered risk engine, the company plans to give customers real-time detection of suspicious access patterns, along with automated responses that can block or escalate authentication challenges.


“Understanding risk is an essential component of a modern access management solution, and this acquisition allows us to deliver greater value to our customers at a faster pace,” said Fran Rosch, CEO of Imprivata. “By integrating Verosint’s capabilities, our platform continuously validates that access is appropriate and authorized… boosting productivity, strengthening security, and reducing costs.”


Verosint’s ITDR technology continuously monitors for anomalies—unusual logins, inconsistent device fingerprints, or unexpected privilege use—and correlates them against enterprise identity intelligence. The result: adaptive defense that keeps access secure without slowing down users.


“Our mission at Verosint has been to help organizations stop identity-based attacks before they cause damage,” said Steve Shoaff, CEO of Verosint. “Joining forces with Imprivata allows us to expand the impact of our technology at enterprise scale, while contributing to a future where access is not only secure, but also effortless for users.”


Passwordless, Zero-Trust, and Built for the Front Line


Imprivata has long been known for secure, streamlined access in healthcare environments—where seconds matter and friction costs lives. Its passwordless zero-trust solution for shared device access, introduced earlier this year, replaced traditional login friction with proximity badges, face recognition, and session persistence designed for nurses and physicians moving between stations.


Adding ITDR enhances that framework with continuous validation, ensuring credentials, devices, and sessions remain trustworthy after the initial login. For clinicians juggling patient care, this invisible defense translates to less interruption and greater safety.


A Unified Vision: From Authentication to Access Intelligence


Beyond risk detection, Imprivata’s broader roadmap integrates several key advances:


  • Passwordless authentication innovations such as FIDO passkeys and integrated facial recognition


  • Operational analytics offering real-time workflow and access visibility


  • Universal compatibility across cloud, SaaS, and legacy systems to unify identity across hybrid infrastructures


  • Personalized access experiences on shared workstations and mobile devices


“Enterprises are looking for ways to improve security without slowing down their workforce,” said Chip Hughes, Chief Product Officer at Imprivata. “Our vision for advanced and passwordless access is about delivering strong authentication behind the scenes, with the intelligence and automation needed to adapt to risk in real time.”


Why It Matters


Identity attacks have become the breach vector of choice for cybercriminals, accounting for more than 70 percent of intrusions in healthcare and critical industries. By bringing ITDR under the Imprivata umbrella, the company isn’t just selling access management—it’s building a living, learning identity defense ecosystem.


The move also marks a broader inflection point: as enterprises embrace AI, identity security must evolve from static control to dynamic resilience. Imprivata’s acquisition of Verosint shows where that future is headed—where identity is no longer a password to guard, but a signal to analyze, predict, and protect.

bottom of page